Literature DB >> 29395479

Insufficient Apaf-1 expression in early stages of neural differentiation of human embryonic stem cells might protect them from apoptosis.

Somayeh Karimzadeh1, Saman Hosseinkhani2, Ali Fathi3, Farangis Ataei1, Hossein Baharvand4.   

Abstract

Recent evidence suggests that mitochondrial apoptosis regulators and executioners may regulate differentiation, without being involved in cell death. However, the involved factors and their roles in differentiation and apoptosis are still not fully determined. In the present study, we compared mitochondrial pathway of cell death during early neural differentiation from human embryonic stem cells (hESCs). Our results demonstrated that ROS generation, cytosolic cytochrome c release, caspases activation and rise in p53 protein level occurred upon either neural or apoptosis induction in hESCs. However, unlike apoptosis, no remarkable increase in apoptotic protease activating factor-1 (Apaf-1) level at early stages of differentiation was observed. Also the caspase-like activity of caspase-9 and caspase-3/7 were seen less than apoptosis. The results suggest that low levels of Apaf-1 as an adaptor protein might be considered as a possible regulatory barrier by which differentiating cells control cell death upon rise in ROS production and cytochrome c release from mitochondria. Better understanding of mechanisms via which mitochondria-mediated apoptotic pathway promote neural differentiation can result in development of novel therapeutic approaches.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apaf-1; Human embryonic stem cell; Mitochondrial apoptosis; Neural differentiation

Mesh:

Substances:

Year:  2018        PMID: 29395479     DOI: 10.1016/j.ejcb.2018.01.005

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  4 in total

1.  Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.

Authors:  Kayhan Mehdizadeh; Farangis Ataei; Saman Hosseinkhani
Journal:  Med Oncol       Date:  2021-04-27       Impact factor: 3.064

2.  Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction.

Authors:  Roghaye Hamidi; Farangis Ataei; Saman Hosseinkhani
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 3.  XIAP as a multifaceted molecule in Cellular Signaling.

Authors:  Mina Hanifeh; Farangis Ataei
Journal:  Apoptosis       Date:  2022-06-04       Impact factor: 5.561

4.  Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug.

Authors:  Meysam Bakhshoudeh; Kayhan Mehdizadeh; Saman Hosseinkhani; Farangis Ataei
Journal:  Med Oncol       Date:  2021-06-28       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.